Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mýsköpun has been researching and cultivating microalgae from the unique geothermal region of Mývatn in Iceland. Their initial results have enabled them to secure funding to establish small-scale production facilities for Spirulina and Chlorella. The company's work leverages local geothermal resources to produce high-nutritional-value algae intended for food supplements, aquaculture feed, and potential pharmaceutical applications. No clinical trial data reported; current focus is on quality control and market entry[3][4].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mýsköpun.